Atkinson Edward Morrow III

EVP, Chief Technical Ops. Off.VERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)817$473.68$387K21K
Feb 17, 2026Grant(A)5K$025K
Feb 17, 2026Tax withholding(F)2K$483.75$740K24K
Feb 17, 2026Sell(S)2K$489.46$994K22K

Transaction Codes

S
Open-market sale
A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000082) within minutes of acceptance. Every field above traces to the original document. Verify it directly: